A Global Perspective of GBA1-Related Parkinson’s Disease: A Narrative Review
Authors:
- Christos KorosCKChristos Koros
- Anastasia BougeaAnastasia Bougea
- Ioanna AlefantiIAIoanna Alefanti
- Athina Maria SimitsiASAthina Maria Simitsi
- Nikolaos PapagiannakisNikolaos Papagiannakis
- Ioanna PachiIPIoanna Pachi
- Evangelos SfikasESEvangelos Sfikas
- Roubina AntonelouRARoubina Antonelou
- Leonidas StefanisLSLeonidas Stefanis
Open Access
Abstract
Parkinson’s disease (PD) is considered to be the second most prominent neurodegenerative disease and has a global prevalence. Glucocerebrosidase (GBA1) gene mutations represent a significant hereditary risk factor for the development of PD and have a profound impact on the motor and cognitive progression of the disease. The aim of this review is to summarize the literature data on the prevalence, type, and peculiarities of GBA1 mutations in populations of different ethnic backgrounds. We reviewed articles spanning the 2000–2024 period. GBA1-related PD has a worldwide distribution. It has long been recognized that pathogenic GBA1 mutations are particularly common in certain ethnic populations, including PD patients of Ashkenazi Jewish ancestry. Moreover, a considerable number of studies focused on European ancestry patients from Europe and North America have revealed a high proportion (up to 15%) of carriers among the PD population. GBA1 mutations also appear to play an important role in patient groups with an East Asian background, although the frequency of specific variants may differ as compared to those of European ancestry. Notably, the assessment of underrepresented populations in other parts of Asia (including India) and Latin America is in the spotlight of current research, while a variant with a newly described pathogenic mechanism has been reported in Sub-Saharan Africans. Given the importance of GBA1 mutations for PD genetics and clinical phenotype, a focused assessment of the prevalence and type of GBA1 variants in distinct ethnic populations will possibly inform ongoing PD-related clinical studies and facilitate upcoming therapeutic trials.Keywords
This publication has 95 references indexed in Scilit:
- Towards a Global View of Parkinson's Disease GeneticsAnnals of Neurology, 2024
- Genome‐Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from IndiaAdvanced Biology, 2022
- A novel Parkinson's disease risk variant, p. W378R, in the Gaucher's disease GBA geneMovement Disorders, 2018
- High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi JewsJAMA Neurology, 2016
- Survival and dementia in GBA‐associated Parkinson's disease: The mutation mattersAnnals of Neurology, 2016
- GBA mutations are associated with Rapid Eye Movement Sleep Behavior DisorderAnnals of Clinical and Translational Neurology, 2015
- Evolution of Prodromal Clinical Markers of Parkinson Disease in aGBAMutation–Positive CohortJAMA Neurology, 2015
- Gaucher disease ascertained through a Parkinson's center: Imaging and clinical characterizationMovement Disorders, 2010
- Mutations for Gaucher Disease Confer High Susceptibility to Parkinson DiseaseArchives of Neurology, 2009
- The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase MutationsArchives of Neurology, 2008